The Wall Street Journal
wsj.com
did:plc:i3fhjvvkbmirhyu4aeihhrnv
Under the deal, Alfasigma will gain rights to develop, manufacture and commercialize linerixibat. on.wsj.com/4sw41wJ https://on.wsj.com/4sw41wJ
2026-03-09T07:44:10.756Z
Enable JavaScript to use Bluesky.
Learn more about Bluesky at bsky.social and atproto.com.